Cresco Labs (CRLBF) Cash from Investing Activities (2019 - 2025)

Cresco Labs (CRLBF) reported Cash from Investing Activities of -$13.2 million for Q4 2025, down 339.5% on a YoY basis from $5.5 million in Q4 2024, and down 116.23% quarter-over-quarter from -$6.1 million in Q3 2025.

Cresco Labs (CRLBF) Cash from Investing Activities (2019 - 2025) Analysis & Trends

Cresco Labs has reported Cash from Investing Activities for 7 years, with the latest figure at -$13.2 million in Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities fell 339.5% year-over-year to -$13.2 million; the trailing twelve-month figure through Dec 2025 stood at -$28.6 million (down 49.61% YoY), and the FY2025 full-year result was -$40.7 million, down 61.34% from the prior year.
  • Cash from Investing Activities for Q4 2025 stood at -$13.2 million, down from -$6.1 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $23.5 million in Q3 2022, with the low at -$64.1 million in Q4 2021.
  • Historically, Cash from Investing Activities has averaged -$16.0 million across 5 years, with a median of -$12.5 million in 2022.
  • Annual changes were most pronounced in 2021 — Cash from Investing Activities tumbled 581.77% — and 2022, when it soared 154.05%.
  • Cresco Labs' Cash from Investing Activities stood at -$64.1 million in 2021, then surged by 80.57% to -$12.5 million in 2022, then surged by 120.95% to $2.6 million in 2023, then sank by 215.48% to -$3.0 million in 2024, then sank by 339.5% to -$13.2 million in 2025.
  • The last three Cash from Investing Activities figures came in at -$13.2 million (Q4 2025), -$6.1 million (Q3 2025), and -$3.0 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 229.00 Mn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn -87.00 Mn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 743.70 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn -506.20 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn -60.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -2.08 Bn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 25.99 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -15.45 Mn
10 Cresco Labs - - 75.45 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -13.24 Mn
Dec 31, 2025 -13.24 Mn
Sep 30, 2025 -6.12 Mn
Sep 30, 2025 -6.12 Mn
Dec 31, 2024 -3.01 Mn
Dec 31, 2024 -3.01 Mn
Sep 30, 2024 -6.27 Mn
Sep 30, 2024 -6.27 Mn
Dec 31, 2023 2.61 Mn
Dec 31, 2023 2.61 Mn
Sep 30, 2023 -12.48 Mn
Sep 30, 2023 -12.48 Mn
Dec 31, 2022 -12.45 Mn
Dec 31, 2022 -12.45 Mn
Sep 30, 2022 23.48 Mn
Sep 30, 2022 23.48 Mn
Dec 31, 2021 -64.11 Mn
Dec 31, 2021 -64.11 Mn
Sep 30, 2021 -43.45 Mn
Sep 30, 2021 -43.45 Mn